Page 104 - PROGRAMME2018

OVERVIEW TUESDAY, 3 JULY 2018
14:00 - 15:00
14:00 - 17:00 14:00 - 15:00
14:00 - 15:00
14:00 - 15:00
15:15 - 16:30 15:15 - 16:30 15:15 - 16:30 15:15 - 16:30
SESSION 43: MHR SYMPOSIUM: FIRST TRIMESTER BIOMARKERS OF IMPAIRED PLACENTATION
• Replication of Cytomegalovirus and Zika virus in first-trimester human placentas, mechanisms of viral pathogenesis and host cell defense
– Lenore Pereira, U.S.A.
• Cell-free fetal hemoglobin as a biomarker of impaired place
– Stefan Hansson, Sweden
SESSION 44: LIVE SURGERY SESSION
SESSION 45: MANAGING EMBRYO STRESS IN PREIMPLANTATION DEVELOPMENT
• Nuclear reprogramming and chromatin functions in oocytes and preimplantation embryos
– K.E. Latham, U.S.A.
• Mitochondrial stress in preimplantation development and opportunities for treatment
– Rebecca Robker, Australia
SESSION 46: PATIENT SESSION: SURROGACY - THE PATIENTS’ PERSPECTIVE
• Surrogacy in Portugal - from struggle to accomplishment
– Ana Galhardo, Portugal
• Surrogacy and stratified kinship – Amrita Pande, South Africa
• What is it like to be a wombless woman in the age of ART’s?
• Patients’ perspectives on gestational surrogacy in Finland
– Kaisa Kivipuro, Finland
SESSION 47: HOW TO INCREASE PEOPLE’S FERTILITY AWARENESS?
• Development and impact of fertility campaigns
– Lone Schmidt, Denmark
• Preconceptional personalised mHealth lifestyle coaching:
First results of a randomized controlled trial in couples undergoing IVF/ICSI treatment
– Régine P.M. Steegers-Theunissen, The Netherlands
SESSION 48: EFFECTS ON TESTICULAR DEVELOPMENT AND GERM CELL DIFFERENTIATION
SESSION 49: PREMATURE OVARIAN INSUFFICIENCY AND POOR OVARIAN RESPONSE
SESSION 50: GENETIC AND EPIGENETIC IMPACT OF ASSISTED REPRODUCTIVE TECHNOLOGIES
SESSION 51: IMMUNOLOGIC AND OTHER TREATMENT OPTIONS IN RM/RIF
Room 211+212
Room 113+114+115
Room 117
Room 116
Forum (Auditorium)
Room 211+212 Room 113+114+115
Room 117
104